Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2021, 30(1):57-61

Eosinophil - "a good servant but a bad master"

Šimovičová V1, Danková M1, Luknár M1, Lesný P1, Lauko V2, Talarčík P3, Gonçalvesová E1
1 Kardiologická klinika LFUK a NÚSCH, a. s. Bratislava, Oddelenie zlyhávania a transplantácie srdca
2 Pracoviska hematológie a transfúziológie NÚSCH, a. s. Bratislava
3 CYTOPATHOS, spol. s r. o., Bratislava, Slovenská republika

Eosinophilic myocarditis (EM) is a rare form of myocarditis with a very heterogeneous etiology. It is characterized by the presence of eosinophilic infiltrate in the myocardium. The course can vary from an asymptomatic clinical picture to life-threatening conditions. We describe a case of a 29-year-old patient with a history of bronchial asthma hospitalized for chestpain and manifesting heart failure. A moderate decrease of ejection fraction of the undilated left ventricle chamber was found. High levels of troponin, NTproBNP and eosinophilia were present in the laboratory findings. By endomyocardial biopsy we confirmed the presence of an eosinophilic infiltrate with a histological pattern of myocarditis. We did not confirm clonal proliferation of eosinophils. Corticoid therapy was initiated. After a week we observed normalization of eosinophils and a decrease in cardiac specific enzymes. Different types of ventricular tachycardias, which required multiple external defibrilation, occured during treatment. An ICD was implanted in the secondary prevention of sudden cardiac death. Ventricular arrhythmias have been stabilized by a combination of pharmacotherapy and individualized programming of ICD functions. Control biopsy was without histological finding of myocarditis. Left ventricular ejection fraction improved by 10%: the patient has been asymptomatic. Eosinophilic myocarditis is a rare disease but with poor prognosis in the acute phase. With the presence of eosinophilia in peripheral blood, this potential cause of acute heart failure should also be considered. Clear diagnosis must be confirmed by endomyocardial biopsy. The basis of treatment is corticoid therapy, which positively affects survival.

Keywords: eosinophilic myocarditis; heart failure; rare diseases

Published: January 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimovičová V, Danková M, Luknár M, Lesný P, Lauko V, Talarčík P, Gonçalvesová E. Eosinophil - "a good servant but a bad master". Cardiology Letters. 2021;30(1):57-61.
Download citation

References

  1. Brambatti M, Matassini MV, Adler ED, et al. Eosinophylic myocarditis characteristics, treatment, and outcomes. J Am Coll Cardiol. 2017;70:2363-2375. Go to original source...
  2. Sheikh H, Siddiqui M, Uddin S, et al. The clinicopathological profile of eosinophilic myocarditis. Cureus. 2018;10:e3677. Go to original source...
  3. Hawkins ET, Levine TB, Goss SJ, et al. Hypersensitivity myocarditis in the explanted hearts of transplant recipients. Reappraisal of pathologic criteria and their clinical implications. Pathol Annu.1995;30:287-304.
  4. Kuchynka P, Palecek T, Masek M, et al. Current diagnostic and therapeutic aspects of eosinophilic myocarditis. Biomed Res Int. 2016;2016:2829583. Go to original source...
  5. Ali AM, Straatman LP, Allard MF, et al. Eosinophilic myocarditis: case series and review of literature. Can J Cardiol. 2006;22:12331237. Go to original source...
  6. Akuthota P and Weller PF. Spectrum of eosinophilic endorgan manifestations. Immunol Allergy Clin North Am. 2015;35:403411. Go to original source...
  7. Cheung ChC, Constantine M, Ahmadi A, et al. Eosinophilic myocarditis. Am J Med Sci. 2017;354:486-492. Go to original source...
  8. Luo T, Kim JK. The role of estrogen and estrogen receptors on cardiomyocytes: an overview. Can J Cardiol. 2016;32:10171025. Go to original source...
  9. Kawano S, Kato J, Kawano N, et al. Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period. Intern Med. 2011;50:975-981. Go to original source...
  10. Caforio ALP, Pankuweit A, Arbustini E, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34:2636-2648. Go to original source...
  11. Ommen SR, Seward, JB and Tajik AJ. Clinical and echocardiographic features of hypereosinophilic syndromes. Am J Cardiol. 2000;86:110-113. Go to original source...
  12. Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59779-792. Go to original source...
  13. Frustaci A, Russo M, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virusnegative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002. Go to original source...